When planning treatment for deep vein thrombosis, interventional teams sometimes face a choice between completing clot removal in a single-session thrombectomy or spreading treatment across more than one visit using a staged approach. Neither strategy is inherently superior; the right choice depends on clot extent, patient stability, and how the procedure unfolds in real time. This article explains the considerations behind each approach.
What Defines a Single-Session Approach?
A single-session, or one-stage, clot removal aims to achieve adequate clearance of the thrombus in one procedural visit, using mechanical thrombectomy, aspiration, or a combination of techniques to clear the vein as completely as reasonably possible before the patient leaves the procedure suite. This approach is often preferred when clot burden is manageable within a reasonable procedure time and the patient's overall condition supports a single, complete intervention.
What Is a Staged Approach?
A staged approach spreads treatment across two or more sessions, sometimes incorporating a period of overnight lysis, where a thrombolytic medication is infused directly into the clot over several hours or overnight between mechanical treatment sessions, allowing the drug additional time to soften and partially dissolve thrombus before a follow-up mechanical pass. This can be useful for very extensive clot burden where completing full clearance in a single sitting would extend procedure time beyond what is considered safe or practical.
Factors That Favor a Single-Session Approach
Patients with more limited or moderate clot burden, good overall procedural tolerance, and no need for extensive additional evaluation of underlying anatomy are often good candidates for completing treatment in one visit. A single-session approach can also reduce the total number of vascular access procedures a patient undergoes, which may be preferable when minimizing cumulative procedural risk is a priority.
Factors That Favor a Staged Approach
Very extensive iliofemoral clot burden, situations where a period of thrombolytic infusion may improve later mechanical clearance, or cases where the patient's overall stability makes a shorter initial procedure preferable can all favor a staged strategy. Staging also allows the interventional team to reassess between sessions, incorporating findings from initial treatment into planning for the subsequent visit.
How Real-Time Findings Influence the Decision
In many cases, the decision between single-session and staged treatment is not made entirely in advance but is refined based on what the interventionalist observes once the procedure is underway. If clot proves more extensive or resistant to clearance than anticipated on pre-procedure imaging, the team may decide mid-procedure to stage the remaining treatment rather than substantially extend the current session.
Weighing Patient Experience and Logistics
Beyond purely clinical factors, staged treatment involves additional hospital time, potential need for continued monitoring between sessions, and an additional procedural visit, which carries its own logistical and recovery considerations for the patient. A qualified physician discusses these trade-offs directly with the patient as part of overall treatment planning, balancing thoroughness of clot removal against the practical burden of multiple procedures.
How is the decision between single-session and staged treatment made?
It is based on a combination of pre-procedure imaging findings regarding clot extent, the patient's overall clinical stability, and real-time findings during the initial procedure, all weighed together by the treating interventional team.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.